SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as users promote the coin and its association with cannabis culture. The community emphasizes the coin's cultural significance, steady growth, and resilience. Some users are also speculating about potential upcoming catalysts such as a CMC listing.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending as investors discuss the company's potential as an AI acquisition target, particularly after recent activity in the data labeling space. Community members are analyzing INOD's recruitment strategies, financial positioning, and technical indicators, interpreting them as signs of a potential takeover or significant new contracts. Bullish sentiment prevails, with focus shifting towards potential short squeezes and price targets.

GME Ethereum

GME Ethereum is trending as the community anticipates a potential "god candle" and a tweet from Roaring Kitty, sparking excitement. Conversations revolve around potential catalysts and the overall bullish sentiment surrounding the coin. Some community members highlight locked liquidity and a "savage" team as reasons for optimism, while others suggest that it is a scam.

KULR Technology Group, Inc. engages in developing, manufacturing, and licensing next-generation carbon fiber thermal management technologies for batteries and electronic systems. Its products include cellcheck, safecase, thermal capacitor, fiber thermal interface, thermal runaway shield, internal short circuit, and cathode. The company was founded by Michael Mo and Timothy R. Knowles in December 2015 and is headquartered in Webster, TX.

KULR Technology Group Inc

KULR is trending due to a surge in volume and community discussion around its Thursday's kBMS launch for defense and space. Bullish sentiment is building, with some eyeing a potential short squeeze and upside to the $7 level. The company's Bitcoin holdings and thermal runaway technology are also being discussed as potential drivers.

ARK Investment Management LLC - ARK Genomic Revolution ETF

ARKG is gaining attention as investors discuss potential breakout patterns and compare its performance to other ARK funds, with some expressing frustration over its historical returns. Community members are actively debating entry points and speculating on future catalysts, particularly the impact of AI on genomic advancements. Despite mixed sentiment regarding management, there's anticipation for a potential sector-wide upswing and the impact of future rate cuts.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMY is trending amidst community disagreement on its potential, with some expressing frustration over its price action relative to Bitcoin's surge and other altcoins. Discussions revolve around potential catalysts, including partnerships and broader market trends, while others dismiss the project as a lost cause, pointing to its ranking decline. The community is split between those who remain optimistic, accumulating more JASMY, and those who are highly critical, predicting further decline.

GSR III Acquisition Corp engages in the merger, share exchange, asset acquisition, share purchase or reorganization with one or more businesses. The company was founded on May 10, 2023 and is headquartered in Austin, Texas.

GSR III Acquisition Corp. - Ordinary Shares- Class A

GSR III Acquisition Corp. Ordinary Shares

GSRT is trending as investors discuss the upcoming October 7th shareholder vote regarding its merger with Terra Innovatum, anticipating a ticker change to NKLR. Community talking points include the company's potential in the nuclear energy sector, especially in micro-modular reactors, and comparisons to peers like OKLO and SMR, highlighting potential undervaluation. The focus remains on the merger's completion and the subsequent impact on the stock's price.

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Prime Medicine Inc

Prime Medicine is trending as the stock experiences increased interest, potentially driven by bullish options activity and renewed excitement around the gene editing space. Community members are actively discussing the company's potential in curing rare diseases and speculating on possible institutional or insider buying. Some investors believe the current administration's focus on healthcare and gene editing could further boost Prime Medicine's prospects.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors celebrate the stock's recent gains, with many long-term holders expressing excitement about breaking past the $40 mark and some anticipating a Nasdaq relisting. Community members are also discussing the company's expansion in China and the U.S., viewing it as a potential challenger to Starbucks, especially as Luckin innovates with new products and offers competitive pricing.

Vulcan Materials Co. engages in the production of construction aggregates. It operates through the following segments: Aggregates, Asphalt, and Concrete. The Aggregates segment produces and sells aggregates and related products and services. The Asphalt segment relates to the production and selling of asphalt mix in Arizona, California, New Mexico, Tennessee, and Texas. The Concrete segment refers to the production and selling of ready-mixed concrete in California, Maryland, and Virginia in addition to the U.S. Virgin Islands and Washington D.C. The company was founded in 1909 and is headquartered in Birmingham, AL.

Vulcan Materials Co

Vulcan Materials is trending due to bullish options activity and speculation around strong construction forecasts, which could boost the company's growth. The community is focused on potential ROI from call options expiring in 2025 and 2026, with some eyeing VMC's position as a leading aggregates and concrete manufacturer. Additionally, mentions of infrastructure and building material sector strength have contributed to the increased attention.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biora Therapeutics announces interim results of BT-600 clinical trial

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap  Platform Development

Mean Plasma Tofacitinib Concentration

 Following administration of a single oral dose of 5 mg and 10 mg BT-600

All pharmacokinetic endpoints were achieved, with a PK profile...

Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced the closing of its previously...

Biora Therapeutics announces $6M registered direct offering and concurrent private placement

Biora Therapeutics announces $6M registered direct offering and concurrent private placement...

Biora Therapeutics Announces $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SAN DIEGO, April 01, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it has entered into...

Biora Therapeutics prices 5.45M shares at $1.10 in registered direct offering

Head-To-Head Comparison: Biora Therapeutics (NASDAQ:BIOR) vs. DURECT (NASDAQ:DRRX)

Biora Therapeutics (NASDAQ:BIOR  Get Free Report) and DURECT (NASDAQ:DRRX  Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the...

Q4 2023 Biora Therapeutics Inc Earnings Call Transcript

Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

All performance targets achieved in single-ascending dose (SAD) cohorts of BT-600 clinical trial Results demonstrated targeted drug delivery and absorption in the colon, with 3-4 times lower...

Earnings Outlook For Biora Therapeutics

Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.

Biora Therapeutics Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

BIOR
Biora Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BIOR News

BIOR Biora Therapeutics Inc